1993
Frequency of left ventricular dysfunction and other echocardiographic abnormalities in human immunodeficiency virus seronegative intravenous drug users
Willoughby S, Vlahov D, Herskowitz A. Frequency of left ventricular dysfunction and other echocardiographic abnormalities in human immunodeficiency virus seronegative intravenous drug users. The American Journal Of Cardiology 1993, 71: 446-447. PMID: 8430637, DOI: 10.1016/0002-9149(93)90451-h.Peer-Reviewed Original ResearchConceptsIntravenous drug usersSeronegative intravenous drug usersIllicit drug useDrug usersDrug useLeft ventricularHIV-seronegative intravenous drug usersHuman immunodeficiency virus (HIV) infectionHIV-seropositive patientsNormal coronary arteriesImmunodeficiency virus infectionLeft ventricular dysfunctionLV ejection fractionGlobal left ventricularDevelopment of cardiomyopathyEchocardiographic abnormalitiesEchocardiographic findingsLV dysfunctionSeropositive patientsVentricular dysfunctionEjection fractionHIV infectionRetrospective reviewImmunodeficiency syndromeCoronary angiogram
1989
Immunological effects of HIV-1 infection on the humoral response to malaria in an African population.
Wabwire-Mangen F, Shiff C, Vlahov D, Kline R, Serwadda D, Sewankambo N, Mugerwa R, Quinn T. Immunological effects of HIV-1 infection on the humoral response to malaria in an African population. American Journal Of Tropical Medicine And Hygiene 1989, 41: 504-11. PMID: 2683820, DOI: 10.4269/ajtmh.1989.41.504.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAdolescentAdultAnimalsAntibodies, ProtozoanAntigens, ProtozoanAntigens, SurfaceCross-Sectional StudiesEnzyme-Linked Immunosorbent AssayFemaleHIV SeropositivityHIV-1HumansMalariaMaleMiddle AgedPlasmodiumPlasmodium falciparumPlasmodium malariaeProtozoan ProteinsUgandaConceptsHIV-1 infectionTrauma patientsClinical AIDSSeronegative patientsAntibody levelsHIV-1HIV-1-seronegative patientsHIV-1 seropositive patientsPolyclonal B cell activationCross-sectional studyHigh malaria transmissionB cell stimulationB cell activationSeropositive patientsImmunodeficiency syndromeMalaria antibodiesHumoral responseImmunological effectsSerological responseStudy groupPatientsCell activationMalaria transmissionControl populationLess antibody